SWOG clinical trial number
SWOG-9403 (E3893)
A Phase II Study of 13-cis Retinoic Acid plus Interferon a- 2a in Advanced Stage Penile Carcinoma.
Closed
Phase
Published
Abbreviated Title
A Phase II Study of 13-cis Retinoic Acid plus Interferon a- 2a in Advanced Stage Penile Carcinoma.
Activated
03/01/1996
Closed
06/17/1998
Publication Information Expand/Collapse
2003
A phase II study of 13-cis retinoic acid plus interferon a-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893)